Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson, Dwight Owen, Karl Haglund, Peter Shields, Erin Bertino, Carolyn Presley, Kai He, Jacob Naduparambil, Steve Walston, Jeff Pan, Xiangyu Yang, Michael Knopp, Jean Koutou Essan, Joseph McElroy, Xiaokui Mo, Sohyun McElroy, David Carbone, Jose Bazan
BACKGROUND: Primary tumor failure is common in patients treated with chemoradiation (CRT) for locally-advanced NSCLC (LA-NSCLC). Stereotactic body radiation therapy (SBRT) yields high rates of primary tumor control (PTC) in early-stage NSCLC. This trial tested an SBRT boost to the primary tumor prior to the start of CRT to improve PTC. MATERIALS/METHODS: Patients with LA-NSCLC received an SBRT boost in 2 fractions (central location 12 Gy, peripheral location 16 Gy) to the primary tumor, followed by standard CRT (60 Gy in 30 fractions)...
February 20, 2024: International Journal of Radiation Oncology, Biology, Physics